Subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy under prolonged stress

The human eye is a delicate instrument, and like any jingmi machine, it can malfunction when the body's internal environment is thrown off balance. One such malfunction is a condition called central serous chorioretinopathy, a disorder where fluid leaks under the retina, the light-sensitive layer at the back of the eye. This fluid accumulation causes the retina to lift slightly, much like a bubble forming under a sticker, leading to blurred or distorted vision. While this condition can happen to anyone, it is strongly linked to high levels of stress. When a person is under intense psychological pressure, their body produces more cortisol, a stress hormone that can weaken the barriers in the eye's blood vessels, allowing fluid to seep through. For decades, doctors have known that chronic stress can turn a temporary episode of this fluid leak into a persistent, long-term problem that damages vision over time.

In recent years, the global shortage of a specific medication used to treat severe cases of this condition has forced doctors to look for alternatives. One such alternative is a type of laser treatment that uses very short, rapid pulses of light. Unlike traditional lasers that burn tissue to seal leaks, this method delivers energy in a way that stimulates the eye's natural repair cells without causing visible damage or scarring. It is a gentler approach, designed to wake up the eye's own pump mechanisms to drain the excess fluid. However, while this treatment has been studied in calm environments, its effectiveness in the most extreme conditions of human stress remained a mystery. With the ongoing war in Ukraine, researchers found themselves in a unique position to observe how this therapy works on two distinct groups of people living under prolonged, life-altering stress: active-duty soldiers and civilians caught in the conflict.

A team of ophthalmologists at the Filatov Institute of Eye Diseases in Ukraine set out to investigate this question directly. They recruited sixty-five patients suffering from chronic central serous chorioretinopathy, dividing them into two groups based on their life circumstances. One group consisted of twenty-nine military personnel who had been exposed to the intense, continuous strain of combat operations, sleep deprivation, and the constant threat to their lives. The other group included thirty-six civilians who were enduring the chronic anxiety of war, dealing with displacement, loss, and the breakdown of their daily lives. Both groups received the same treatment: a series of sessions using a green laser that emits light at a specific wavelength of 577 nanometers. The doctors carefully adjusted the power of the laser for each patient, titrating it down until it was just below the threshold of causing a burn, ensuring the treatment remained subthreshold and safe.

Over the course of a year, the researchers tracked the progress of every patient, measuring their vision and examining the structure of their retinas with high-resolution imaging. The results showed a clear and positive trend for everyone involved. By the end of the twelve-month study, the average vision of the entire group had improved significantly. The military patients, who started with an average vision score of 0.65, saw their vision rise to 0.73. The civilian patients, who began at 0.66, improved to 0.77. When the researchers compared the two groups at the final visit, they found no meaningful difference in how well the patients could see; both groups had recovered to a similar level of visual function. The laser treatment had successfully helped the eyes of people living in the midst of a war zone to heal.

Beyond just vision, the study looked at the physical changes happening inside the eye. The fluid that had been lifting the retina, known as subretinal fluid, began to disappear in the majority of patients. In the overall group, sixty percent of the patients saw the fluid completely vanish. The military group saw a complete resolution in fifty-two percent of cases, while the civilian group saw it in sixty-seven percent. The thickness of the retina, which had been swollen by the fluid, returned to normal levels in both groups. The height of any detached layers of tissue also decreased significantly. These anatomical improvements confirmed that the laser was effectively helping the eye drain the fluid and restore its normal structure, even while the patients remained under the heavy burden of wartime stress.

However, the path to recovery was not identical for everyone. While the final outcome was the same, the military patients required more frequent treatment sessions to get there. On average, the soldiers needed nearly two laser sessions to achieve their results, whereas the civilians needed fewer than one and a half sessions on average. This difference was statistically significant, suggesting that the intense, unrelenting nature of combat stress may cause the fluid to return more often or resist treatment slightly longer than the stress experienced by civilians. The soldiers had to undergo more retreatments to maintain the same level of healing, yet they ultimately reached the same destination. The study found no serious side effects or complications from the laser treatment in either group, confirming that the method is safe even for those under extreme duress.

The findings offer a hopeful perspective for doctors treating patients in crisis zones. The study demonstrates that this specific laser therapy is a reliable and effective tool for managing chronic eye disease, even when the patient's life is defined by prolonged stress. It suggests that while the intensity of the stress might dictate how many times a patient needs to return for treatment, it does not prevent the eye from healing. The researchers noted that the soldiers' need for more sessions likely reflects the relentless nature of their environment, where sleep is scarce and pressure is constant, but it does not mean their eyes are less capable of recovery. The study concludes that this treatment should be considered a primary option for patients in such difficult circumstances, particularly when other therapies are unavailable. It provides a clear path forward for preserving vision in the face of adversity, proving that even in the most challenging conditions, the eye's ability to heal can be supported with the right care.